West-Ward Parent Hikma Acquires Egypt’s Alkan Pharma
This article was originally published in The Pink Sheet Daily
Multinational Hikma will strengthen its presence in the Middle East/North Africa market with $60.5 million purchase.
You may also be interested in...
Jordanian drug maker Hikma Pharmaceuticals PLC acquired 63.9% of Moroccan branded generics firm Promopharm SA Oct. 3 in a cash deal worth $111.2 million. The acquisition gives Hikma access to the fourth largest pharmaceutical market in the Middle East and North Africa, additional manufacturing capacity and capability, and a perhaps stronger claim to its goal of being a partner of choice for multinationals across the MENA region
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.